293 related articles for article (PubMed ID: 26994345)
1. Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection.
Huang Z; Gan J; Long Z; Guo G; Shi X; Wang C; Zang Y; Ding Z; Chen J; Zhang J; Dong L
Biomaterials; 2016 Jun; 90():72-84. PubMed ID: 26994345
[TBL] [Abstract][Full Text] [Related]
2. Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes.
Jing Z; Li Y; Song J; Zang X
Int J Biol Macromol; 2023 Dec; 253(Pt 3):126912. PubMed ID: 37722648
[TBL] [Abstract][Full Text] [Related]
3. Targeted Delivery of miRNA 155 to Tumor Associated Macrophages for Tumor Immunotherapy.
Zang X; Zhang X; Zhao X; Hu H; Qiao M; Deng Y; Chen D
Mol Pharm; 2019 Apr; 16(4):1714-1722. PubMed ID: 30860846
[TBL] [Abstract][Full Text] [Related]
4. High level of mature tumor-infiltrating dendritic cells predicts progression to muscle invasion in bladder cancer.
Ayari C; LaRue H; Hovington H; Caron A; Bergeron A; Têtu B; Fradet V; Fradet Y
Hum Pathol; 2013 Aug; 44(8):1630-7. PubMed ID: 23574787
[TBL] [Abstract][Full Text] [Related]
5. Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus Calmette-Guérin immunotherapy.
Ayari C; LaRue H; Hovington H; Decobert M; Harel F; Bergeron A; Têtu B; Lacombe L; Fradet Y
Eur Urol; 2009 Jun; 55(6):1386-95. PubMed ID: 19193487
[TBL] [Abstract][Full Text] [Related]
6. Identification of a Novel Toll-like Receptor 7 Endogenous Ligand in Rheumatoid Arthritis Synovial Fluid That Can Provoke Arthritic Joint Inflammation.
Kim SJ; Chen Z; Essani AB; Elshabrawy HA; Volin MV; Volkov S; Swedler W; Arami S; Sweiss N; Shahrara S
Arthritis Rheumatol; 2016 May; 68(5):1099-110. PubMed ID: 26662519
[TBL] [Abstract][Full Text] [Related]
7. Combination antitumor immunotherapy with VEGF and PIGF siRNA via systemic delivery of multi-functionalized nanoparticles to tumor-associated macrophages and breast cancer cells.
Song Y; Tang C; Yin C
Biomaterials; 2018 Dec; 185():117-132. PubMed ID: 30241030
[TBL] [Abstract][Full Text] [Related]
8. Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages.
Qian Y; Qiao S; Dai Y; Xu G; Dai B; Lu L; Yu X; Luo Q; Zhang Z
ACS Nano; 2017 Sep; 11(9):9536-9549. PubMed ID: 28858473
[TBL] [Abstract][Full Text] [Related]
9. miRNA let-7b modulates macrophage polarization and enhances tumor-associated macrophages to promote angiogenesis and mobility in prostate cancer.
Wang Z; Xu L; Hu Y; Huang Y; Zhang Y; Zheng X; Wang S; Wang Y; Yu Y; Zhang M; Yuan K; Min W
Sci Rep; 2016 May; 6():25602. PubMed ID: 27157642
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of oligonucleotides into tumor-associated macrophages for cancer immunotherapy.
Huang Z; Zhang Z; Jiang Y; Zhang D; Chen J; Dong L; Zhang J
J Control Release; 2012 Mar; 158(2):286-92. PubMed ID: 22119956
[TBL] [Abstract][Full Text] [Related]
11. Splenectomy reduces lung metastases and tumoral and metastatic niche inflammation.
Stöth M; Freire Valls A; Chen M; Hidding S; Knipper K; Shen Y; Klose J; Ulrich A; Ruiz de Almodovar C; Schneider M; Schmidt T
Int J Cancer; 2019 Nov; 145(9):2509-2520. PubMed ID: 31034094
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Aerosol Delivery of Let-7b microRNA Confers a Striking Inhibitory Effect on Lung Carcinogenesis through Targeting the Tumor Immune Microenvironment.
Zhang Q; Pan J; Xiong D; Wang Y; Miller MS; Sei S; Shoemaker RH; Izzotti A; You M
Adv Sci (Weinh); 2021 Sep; 8(17):e2100629. PubMed ID: 34236760
[TBL] [Abstract][Full Text] [Related]
13. Systemic Inflammation Induced by microRNAs: Endometriosis-Derived Alterations in Circulating microRNA 125b-5p and Let-7b-5p Regulate Macrophage Cytokine Production.
Nematian SE; Mamillapalli R; Kadakia TS; Majidi Zolbin M; Moustafa S; Taylor HS
J Clin Endocrinol Metab; 2018 Jan; 103(1):64-74. PubMed ID: 29040578
[TBL] [Abstract][Full Text] [Related]
14. Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages.
Moradi-Chaleshtori M; Shojaei S; Mohammadi-Yeganeh S; Hashemi SM
Life Sci; 2021 Oct; 282():119800. PubMed ID: 34245773
[TBL] [Abstract][Full Text] [Related]
15. Target delivery selective CSF-1R inhibitor to tumor-associated macrophages via erythrocyte-cancer cell hybrid membrane camouflaged pH-responsive copolymer micelle for cancer immunotherapy.
Wang Y; Luan Z; Zhao C; Bai C; Yang K
Eur J Pharm Sci; 2020 Jan; 142():105136. PubMed ID: 31704343
[TBL] [Abstract][Full Text] [Related]
16. Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer.
Lao L; Fan S; Song E
Adv Exp Med Biol; 2017; 1026():331-370. PubMed ID: 29282692
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated macrophages and anti-tumor therapies: complex links.
Belgiovine C; D'Incalci M; Allavena P; Frapolli R
Cell Mol Life Sci; 2016 Jul; 73(13):2411-24. PubMed ID: 26956893
[TBL] [Abstract][Full Text] [Related]
18. The role of tumor-associated macrophage in breast cancer biology.
Choi J; Gyamfi J; Jang H; Koo JS
Histol Histopathol; 2018 Feb; 33(2):133-145. PubMed ID: 28681373
[TBL] [Abstract][Full Text] [Related]
19. Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment.
Wang Y; Lin YX; Qiao SL; An HW; Ma Y; Qiao ZY; Rajapaksha RP; Wang H
Biomaterials; 2017 Jan; 112():153-163. PubMed ID: 27768970
[TBL] [Abstract][Full Text] [Related]
20. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy.
Zhan X; Jia L; Niu Y; Qi H; Chen X; Zhang Q; Zhang J; Wang Y; Dong L; Wang C
Biomaterials; 2014 Dec; 35(38):10046-57. PubMed ID: 25245263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
